ãã·ããã¼æäºãå½éã¨ã¤ãºå¦ä¼ã¯18æ¥å£°æãåºããã¦ã¯ã©ã¤ãæ±é¨ã§å¢è½ãããã¬ã¼ã·ã¢èªç©ºæ©ã«ããªã¼ã¹ãã©ãªã¢ã§éãããå½éã¨ã¤ãºä¼è°ã«åºå¸äºå®ã®ç 究è ããå¤æ°æä¹ãã¦ããã¨æããã«ãããç 究è ãã¯ã¯ã¢ã©ã«ã³ãã¼ã«ã§ä¹ãç¶ãã豪å·ã«åããã¯ãã ã£ãã ä¼è°ã¯è±ªåæ±é¨ã¡ã«ãã«ã³ã§20ã25æ¥ã«éãããã¯ãªã³ãã³å 米大統é ã®è¬æ¼ãäºå®ããã¦ããã
女æ§ã®ä½å ã«åãè¾¼ã¾ãããã«ã¢ã³ãåæ³ãããã¤ã¯ããããããM.I.T.ã®ãã¡ã©ææãã®ãã¼ã ãéçºããã 20ããªè§ã»é«ã7ããªã®ãããã¯ãã¬ããã«ã²ã¹ãã¬ã«ã¨ãã°ãããã«ã¢ã³ãæ¯æ¥ä¸å®éã16å¹´éã«ããã£ã¦ä½å ã«éãè¾¼ãæ©è½ãæã¤ããã®ãã«ã¢ã³ã«ã¯å¥³æ§ã®å¦å¨ ãé²ãæ§è³ªããããã¤ã¾ãããã®ãã¤ã¯ããããã¯æ°ããé¿å¦ç¨ããã¤ã¹ãªã®ã ã ãã«ã¢ã³ã®åæ³ã¯ãç¡ç·ã³ã³ããã¼ã«ã«ãã£ã¦ãã¤ã§ãåæ¢ã»åéã§ããããã®ä¾¿å©ãã®è£è¿ãã¨ãã¦ã第ä¸è ã«ãã£ã¦èª¤ã£ã¦ããããã¯æªæãæã£ã¦ãããããæä½ãããæãããããéä¿¡ã®æå·åãªã©ã«ãã£ã¦ããã®ãããªèª¤ç¨ã»æªç¨ãé²ããã¨ãå®ç¨åã¸ã®èª²é¡ã ã ãã®ãããªåè¾¼ã¿ï¼ã¤ã³ãã©ã³ãï¼åã®å»çæè¡ã«ã¯ãªã¹ã¯ããããããã以ä¸ã«ãä»ã¾ã§ã®å»çã¨ã¯ç°ãªãã¡ãªãããããããã¦ãããã ããã ãã®æ°ããé¿å¦å ·ã¯ããã«ï¼ã¡ãªã³ãã»ã²ã¤ã財å£ã®æ¯æ´ã«ãã£ã¦éçºããããã®ãæ¥å¹´ã
æ ¹ç®¡æ²»çããªããªãï¼ æ¯ã«ã¬ã¼ã¶ã¼å½ã¦ã¦åçããæ°æè¡2014.06.03 23:00 satomi ï½¢åã£ãæ¯ã¯å ã«æ»ããªãï½£â¦ã®å¸¸èãéå»ã®ãã®ã«ãªãããã§ãã æ¯ã®æ ¹ã£ãã¾ã§ãã¼ã³ã£ã¦æã£ã¦ããã¨ãé³ãèããªããæ²ãããªã£ã¦ãã¾ãã¾ããã©ãã¬ã¼ã¶ã¼ä¸çºå½ã¦ãã ãã§æ¯ãåçã§ããæ°ææ³ãè¦ã¤ããã¾ãããä½åºåã¬ã¼ã¶ã¼ã§æ¯ã®å¹¹ç´°èãåºæ¿ãã¦ããã¨ããªãã¨è±¡ç質ï¼æ¯ã®çãä¸ã«ãã硬ãã¨ãï¼ãããç¨åº¦è²ã£ã¦ãã¡ãããã§ãã£ã¦ãï¼ ãã¼ãã¼ã大çããç 究ãã¼ã ã5ææ«ãï½¢Science Translational Medicineï½£ã§çºè¡¨ãããã®ã ä»ã®æ¯ç§æ²»çã§ã¯è±¡ç質ã¯ãã¡ã«ãªã£ããè ã£ãã¨ãåã£ã¦ãè©°ããã®ãæ ¹ç®¡å å¡«æã«ç½®ãæããªããããã¾ãããããã§ãç 究çãç®ãã¤ããã®ã¯ãï½¢ä½åºåã®ã¬ã¼ã¶ã¼ãå½ã¦ã¦ããã¨ç®èãæ¯é«ªã®çºéãä¿ãããï½£ãã¨ã示ãäºä¾å ±åã§ãï¼ãã¡ããé«åºåã¬ã¼ã¶ã¼ã¯æ£å
ããªï¼Parisï¼å¸å ã«ãããã©ã³ã¹è¡æ¶²æ©æ§ï¼French Institution for BloodãEFSï¼è¡æ¶²åéã»ã³ã¿ã¼ã«ä¸¦ã¶ãè¡æ¶²æ¤æ»ç¨ã®è©¦é¨ç®¡ï¼2012å¹´7æ6æ¥æ®å½±ãè³æåçï¼ã(c)AFP/MARION BERARD ã5æ5æ¥ AFPãå¹´é·ã®ãã¦ã¹ã«è¥ããã¦ã¹ã®è¡æ¶²ãæ³¨å ¥ããã¨ããã¦ã¹ã®å¦ç¿è½åã¨è¨æ¶åãé«ã¾ãã¨ããç 究è«æãã4æ¥ã®è±å»å¦èªããã¤ãã£ã¼ã»ã¡ãã£ã¹ã³ï¼Nature Medicineï¼ãã«æ²è¼ããããè¥ãè¡æ¶²ã¯ãèåããè³ã®æ©è½ä½ä¸ã«å¯¾ããæ²»çè¬ã«ãªããããããªãã ç±³ã«ãªãã©ã«ãã¢å¤§å¦ãµã³ãã©ã³ã·ã¹ã³æ ¡ï¼University of California, San Franciscoï¼ãªã©ã®ç 究ãã¼ã ãçºè¡¨ããè«æã«ããã¨ã人éã®å¹´é½¢ã§20ï½30æ³ã«ç¸å½ããçå¾3ãæã®ãã¦ã¹ãã輸è¡ãè¤æ°åè¡ã£ãã¨ãããå56ï½69æ³ã«ç¸å½ããçå¾18ãæã®ãã¦ã¹ã®è³ã®æ§é
ï¼æï¼ï¼æ¥ãä¸çä¿å¥æ©é¢ï¼ï¼·ï¼¨ï¼¯ï¼ã¯ãæãå¼·åãªæçç©è³ªããå¹ããªãèæ§èãä¸çã§æ¡å¤§ãã¦ããã¨ããå ±åæ¸ãçºè¡¨ãåçã¯ï¼·ï¼¨ï¼¯ã®ãã¯ãäºåå±é·è£ãæ¨å¹´ï¼ææ®å½±ï¼ï¼ï¼ï¼ï¼å¹´ããã¤ã¿ã¼/Denis Balibouseï¼ ï¼»ãã³ãã³ãï¼ï¼æ¥ããã¤ã¿ã¼ï¼½ - ä¸çä¿å¥æ©é¢ï¼ï¼·ï¼¨ï¼¯ï¼ã¯ï¼ï¼æ¥ãæãå¼·åãªæçç©è³ªããå¹ããªãèæ§èãä¸çã§æ¡å¤§ãã¦ããã¨ããå ±åæ¸ãçºè¡¨ããã
å¿èã¯ãã©ããã£ã¦è¦åæ£ããé¼åãçã¿åºãã¦ããã®ãããªãºã çºçã®ä»çµã¿ããå½ç«å¾ªç°å¨ç ç 究ã»ã³ã¿ã¼ï¼å¤§éªåºå¹ç°å¸ï¼ãªã©ãã³ã³ãã¥ã¼ã¿ã¼ã·ãã¥ã¬ã¼ã·ã§ã³ã§è§£æãããä¸æ´èã®ç æ 解æãå¿èã®åçå»çå®ç¾ãªã©ã«å½¹ç«ã¤å¯è½æ§ãããã¨ããããå¿èã®é¼åã¯ãå¿èã®å³ä¸é¨ã«ãããæ´çµç¯ï¼ã©ããã£ãã¤ï¼ãã¨ããçµç¹ãçºä¿¡æºã«ãªã£ã¦ããã人éã§ç¸¦ï¼ã»ã³ãã横ï¼ããªãåãï¼ããªç¨åº¦ã¨ããå°ããªçµç¹ã®ç´°èä¸ã¤ä¸ã¤ãé»æ°ä¿¡å·ãåºããå¿èå ¨ä½ã®è¦åæ£ãããªãºã ãä½ããã ãã詳ããä»çµã¿ã¯åãã£ã¦ããªãã£ãããå½å¾ªã®ç¨²ç°æ ï¼ããï¼ã»ç 究æ å ±åºç¤ç®¡ç室ç¹ä»»ç 究å¡ãã¯ã大ãããé»æ°çãªæ§è³ªãå¾®å¦ã«éãæ´çµç¯ã®ç´°èã¢ãã«ãã³ã³ãã¥ã¼ã¿ã¼ä¸ã«ä½ããç´ï¼åéãã®çµã¿åããã§ãé»æ°ä¿¡å·ã®çºçã¨ä¼ããæ¹ã解æããã
å·èµåº«ããªãæ代ãçä¹³ã«ããããå ¥ãããã·ã¢äººã¯å大2014.04.28 08:0011,897 satomi å·èµåº«ãç¾ããåããã·ã¢ã§ã¯æãããã±ã1æ¯ã®çä¹³ã«ãããã1å¹è½ã¨ãã¦è ãã®ãé²ããã¨ããçæ´»ã®ç¥æµãããã¾ããã ä»ã¨ãªã£ã¦ã¯è¿·ä¿¡ã§çä»ãããã¦ãã¾ãããã¢ã¹ã¯ã¯å·ç«å¤§å¦ã®ææ©åå¦è Albert Lebedevå士çãããã¼ã ã調ã¹ã¦ã¿ãããããªãã¡è¿·ä¿¡ã§çä»ããããªãã¡ãªããããããã¨ããããã¾ãããã¾ããããããæ³³ãã§ãçä¹³ã飲ãã®ã¯ã¢ã¬ã§ããã©ãã å·èµç®±ï¼Ice boxï¼ãåãã¦å¸è²©ãããã®ã¯19ä¸ç´åã°ãæ°·ã¯ä¸å¤§ç£æ¥ã«çºå±ãã¾ãã 主ç£å°ã¯ãã¥ã¼ã¤ã³ã°ã©ã³ãã¨ãã«ã¦ã§ã¼ã§ãããå¯ãå°æ¹ã¯ã©ããæ°·ã大ããªè¼¸åºåç®ã¨ãªãã¾ãããå·èµç®±ã¯æ®éã¯å¤ãæ¨è£½ã§ãä¸ã¯é«ãäºéã®å£ã«ãªã£ã¦ã¦ãéã«ãããããã³ã«ã¯ããããªããã®æç±æãè©°ãããã®ã1930年代ã«é»æ°å·èµåº«ãç»å ´ãã¦å»
ãã©ã³ã¹æ±é¨ã¢ã³ã¸ã§ã«ããªã¨ï¼Angervilliersï¼ã®è人ãã¼ã ã®å»ä¸ãæ©ãã¢ã«ããã¤ãã¼ç ã®å¥³æ§ï¼2011å¹´3æ18æ¥æ®å½±ãè³æåçï¼ã(c)AFP/SEBASTIEN BOZON ã3æ10æ¥ AFPãå°æ¥ã¢ã«ããã¤ãã¼ç ãçºçãããã©ãããäºæ¸¬ããè¡æ¶²æ¤æ»ã®è©¦é¨çãéçºããã¨ãç±³ç 究ãã¼ã ã9æ¥ã®è±å»å¦èªããã¤ãã£ã¼ã»ã¡ãã£ã¹ã³ï¼Nature Medicineï¼ãã«çºè¡¨ãããè¡ä¸å ã®è質ãããã¤ãªãã¼ã«ã¼ãã¨ããåã®æ¤æ»æ¹æ³ã§ãç¾å¨å¥åº·ãªäººã3年以å ã«ã¢ã«ããã¤ãã¼ç ãçºçãããå¦ãã90ï¼ ã®ç²¾åº¦ã§äºè¦ã§ããã¨ããã ã¢ã«ããã¤ãã¼åèªç¥çã¯ãè³ç´°èãç ´å£ããæ害ãªã¿ã³ãã¯è³ªã«ãã£ã¦å¼ãèµ·ãããããç¾å¨ã¯æ²»çæ³ããªããè´å½çãªå¤æ§ç¾æ£ã ãä¸çä¿å¥æ©é¢ï¼WHOï¼ã«ããã¨æ£è ã¯ä¸çã§ç´3500ä¸äººã«ä¸ãã2050å¹´ã¾ã§ã«1å1500ä¸äººã«éããã¨äºæ³ããã¦ããã ç±³ã¸ã§ã¼ã¸ã¿ã¦ã³å¤§
ç·æ§ã®ç²¾åã®åç²¾è½åãï¼ï¼æ³ãå¢ã«ä½ä¸ããå¾åããç¬åå»ç§å¤§è¶è°·ç é¢ï¼å¼ççï¼ã®å²¡ç°å¼ææãã®ã°ã«ã¼ãã®ç 究ã§æããã«ãªã£ããï¼ï¼æ¥ããæ±äº¬é½å ã§éãããæ¥æ¬ç£ç§å©¦äººç§å¦ä¼ã§çºè¡¨ãããä¸å¦ã¯æ©å©åã®é²è¡ã«ãã女æ§ã®ãåµåã®èåããªã©ã主ãªåå ã¨ã¿ããã¦ããããç²¾åã®èåãå½±é¿ãã¦ããå¯è½æ§ãããã岡ç°ææã«ããã¨ãç·æ§ã®å é½¢ã«ãã£ã¦åç²¾è½åãä½ä¸ãããã¨ãå®è¨¼ãããã®ã¯åãã¦ãã岡ç°ææãã¯äººéã®ç²¾åããã¦ã¹ã®åµåã«æ³¨å ¥ããåµåãæ´»æ§åãããã©ããã確ããããã¨ã§ç²¾åã®åç²¾è½åã調ã¹ããçºçã®åæ段éã¯ãåºä¹³é¡ã«å ±éã®ã¡ã«ããºã ãåãã¦ããããã人éã®ç²¾åã§ããã¦ã¹ã®åµåã¯åå¿ãã¦æ´»æ§åããããåç²¾è½åããªãç²¾åã ã¨æ´»æ§åããªãããå®é¨ã§ã¯ç·æ§ä¸å¦å¤æ¥ãå診ããç·æ§ã®ãã¡ã精液æ¤æ»ã§ç°å¸¸ãè¦ãããªãï¼ï¼ï½ï¼ï¼ä»£ã®ç·æ§ï¼ï¼äººã®ç²¾åããããããè¤æ°ã®ãã¦ã¹ã®åµåã«é¡å¾®é¡ã使ã£ã¦æ³¨å ¥ãããé¡å¾®æ
ãã®ç»åã大ããªãµã¤ãºã§è¦ã æ°´ã®ä¸ã«ãã£ã¨æ½ã£ã¦ãããããã©ããªã«ç´ æ´ãããä¸çã«å·¡ãåããã®ã ããï¼ã®ãã¹è¨é²ã«ããã¨äººéãæ¯ãæ¢ãã¦æ°´ã®ä¸ã«ãããã¨ã®ã§ããæé«è¨é²ã¯ãã³ãã¼ã¯ç·æ§ã®22åã ããã ãã常人ãªã1åãéçã ããã ã ãããããããè¿ãå°æ¥ã人éãä¸æ©äººéã«è¿ã¥ããæ¥ãæ¥ããããããªããæè¿ã®ç 究ã§ãéèã«æ³¨å°ãããã¨ã§ãæ°´ã®ä¸ã«ãã£ã¨æ½ã£ã¦ããããå¾®ç²åé ¸ç´ ãéçºãããã®ã ããã ã ç±³ãã¹ãã³å¤§å¦å°å ç é¢ã®ç 究ãã¼ã ã«ãã£ã¦éçºãããè質ãã¼ã¹ã®é ¸ç´ å¾®ç²åã¯ãé ¸ç´ ã¬ã¹ã®å°ããªæ³¡ãèãè質ã®å±¤ã§éãè¾¼ãããã®ã§ããã®ç²åãéèã«æ³¨å°ããã¨4ç§ä»¥å ã«è¡ä¸ã«70ï¼ ã®é ¸ç´ ã溶ãããè¡ä¸ã§é ¸ç´ ãéã¶èµ¤è¡çã®3åï½4åã®é ¸ç´ ãèãããã¨ãã§ããè¡æ¶²ä¸ã®é ¸ç´ ã¬ãã«ã15åãã30åã®éæ£å¸¸å¤ã«ä¿ã¤ãã¨ãã§ããã¨ããã ãã®ç»åã大ããªãµã¤ãºã§è¦ãvia:fromquarkstoqua
京é½å¤§å¦ã®ä¸è¾»æ²å¤«ææãã¯æ¥ç£åå¦å·¥æ¥ã¨å ±åã§ãä½ã®æ§ã ãªç´°èã«ãªãiPSç´°èã大éã«å¢ããæ°ããå¹é¤æ³ãéçºãããå¾æ¥ã®10åã®1ã®ã³ã¹ãã§æ²»çã«ä½¿ãéã®iPSç´°èã確ä¿ã§ãããç¾ç¶ã®ã¾ã¾ã ã¨1åä¸ï½2åä¸åãããã¨ãããåçå»çã®æ²»çè²»ããå é²å»ç並ã¿ã®æ°ç¾ä¸åã«å¼ãä¸ãããããä»å¾ãå¯å£«ãã¤ã«ã ãããããªã©ãåå ã5å¹´å¾ãç®æ¨ã«å®ç¨åãããç 究ææã¯ç±³ç§å¦èªãã¹ãã ã»ã»ã«ã»ãªãã¼ãï¼é»å
åå¦è ã®ã¤ã¶ãã æ¦è£ æä½âåå¦è ãè²¢ç®ã§ãããã¤ã³ãã¨ã¯? 2014/4/23 åå¦è ã®ã¤ã¶ãã, è«æ ADC, ãã¤ãªå»è¬, åµè¬åå¦, æä½-å»è¬è¤åä½, æä½å»è¬, çä½å ±å½¹åå¿ æ稿è : cosine æ¦è£ æä½ï¼armed antibodyãããã¯antibody-drug conjugate, ADCï¼ã¨ã¯ãç¾ç ç´°èãèªèããæä½ã¨ãæ´»æ§æ¬ä½ã§ããè¬å¤ããé©åãªãªã³ã«ã¼ã§ã¤ãªãã§ä½ãããå»è¬åã§ããããã®å¤ãã¯ããæ²»çãç®çã«éçºãé²ãããã¦ãã¾ã(ç»åï¼http://www.dddmag.com/)ããçç©ç±æ¥ã®ãã®ãåå¦ã®åã§ããè¯ããã®ã«ãã¨ããææ³ã«åºã¥ããããæå 端åå¦ã®è©±æãã«ã¯æãç«ããªãå»è¬ã§ãããã¾ãï¼æ¦è¦ã¯ãã¡ãã®ã±ã ã¹ãè¨äºãã覧ãã ããï¼ã ããæè¿ãæ¦è£ æä½ã®çºå±ãã¾ã¨ããç·èª¬[1]ãAngew. Chem. Int. Ed.èªã«ç»å ´ãã¾ãããããã
ä»ãªã¨ã³ï¼Lyonï¼è¿éããã³ï¼Bronï¼ã®ç 究æã§æ®å½±ãããå®é¨ç¨ã®ãã¦ã¹ï¼2014å¹´1æ23æ¥æ®å½±ãè³æåçï¼ã(c)AFP/PHILIPPE MERLE ã4æ24æ¥ AFPãã¢ã«ããã¤ãã¼ç ã®ãã¦ã¹ã使ã£ãå®é¨ã§å¤±ãããè¨æ¶ãéºä¼åæ²»çã§å復ãããã¨ã«æåããã¨ã®ç 究çµæãã23æ¥ã®ç±³å°éèªãç¥çµç§å¦ã¸ã£ã¼ãã«ï¼Journal of Neuroscienceï¼ãã«æ²è¼ãããã ã¹ãã¤ã³ã®ãã«ã»ããèªæ²»å¤§å¦ï¼Autonomous University of Barcelonaï¼ã®ç 究ãã¼ã ã¯éºä¼åçµã¿æããã¦ã¹ã使ã£ãå®é¨ã§ãè¨æ¶ã«é¢ä¿ããè³ã®æµ·é¦¬ã«ãã¢ã«ããã¤ãã¼ç ã®æ£è ã§é»å®³ãããã¿ã³ãã¯è³ªãçæããéºä¼åãæ³¨å ¥ããã ãéºä¼åæ²»çã«ããæ³¨å ¥ãããã¿ã³ãã¯è³ªã¯ãé·æè¨æ¶ã®åºå®ã«é¢ä¸ããéºä¼åã®æ´»æ§åã«å¿ è¦ãªä¿¡å·ãåä½ããããã¨å大ã¯å£°æã§è¿°ã¹ãã ãä»åã®ç 究ãã人éã§ããããã®
å½å ã§ã¯4人ã«1人ãçºçãã¦ããã¨æ¨å®ããããã¯ããå½æ°ç ãã¨ãããããè±ç²çãããã¾ã§ã¯å¯¾ççæ³ãä¸å¿ã ã£ãããä»å¹´1æãæãæ£è ãå¤ãã¹ã®è±ç²ã¸ã®ã¢ã¬ã«ã®ã¼ä½è³ªãæ²»ãèä¸å ç«çæ³ã®æ°è¬ãæ¿èªããããæ©ããã°10æã«å¥åº·ä¿éºã®å¯¾è±¡ã«ãªããå°éå»ã®ä¸ã§æ°ããªæ²»çãå§ã¾ãè¦éãã ãä»å¹´ã®è±ç²é£æ£ã®ãã¼ã¯ã¯éããããæ¥ã·ã¼ãºã³ã«åãæ£è ã®é¢å¿ã¯é«ã¾ã£ã¦ãããæ±äº¬é½å ã®60代ç·æ§ã¯10æ°å¹´åããæ¯å¹´
人éããã¯å¦ä¼ã¯ã人éããã¯ãå診ãããããï¼ä¸äººã®å¥åº·ãªäººã®ãã¼ã¿ã解æããçµæãè¡å§ãã³ã¬ã¹ããã¼ã«ã®å¤ãªã©ã«ã¤ãã¦ãç¾å¨ã®å¥åº·è¨ºæã§æ£å¸¸ã¨ããã¦ããæ°å¤ã®ç¯å²ãå¤§å¹ ã«ç·©ããã¹ãã ã¨ãã調æ»çµæãã¾ã¨ãã¾ããã 人éããã¯å¦ä¼ã¨å¥åº·ä¿éºçµåã§ä½ãå°å§å¡ä¼ã¯ãå¹³æï¼ï¼å¹´ã®ï¼å¹´éã«äººéããã¯ãå診ãããããï¼ï¼ï¼ä¸äººã®ãã¡ãæç ããªããã»ã¨ãã©ã®æ¤æ»é ç®ã§ç°å¸¸ãªå¤ããªãå¥åº·ãªäººããããï¼ä¸äººã®ãã¼ã¿ã解æããæ£å¸¸ã¨ãããæ°å¤ã®ç¯å²ã調ã¹ã¾ããã ãã®çµæãè¡å§ã¯ãç¾å¨æ£å¸¸ã¨ãããæ°å¤ããä¸ã®å¤ã¯ï¼ï¼ï¼ã¾ã§ãä¸ã®å¤ã¯ï¼ï¼ã¾ã§ã§ãããä¸ã®å¤ã¯ï¼ï¼ï¼ã¾ã§ãä¸ã®å¤ã¯ï¼ï¼ã¾ã§ã¨ãªã£ãã¨ãããã¨ã§ãã ã¾ãè¥æºåº¦ã表ãï¼¢ï¼ï¼©ã®å¤ã¯ãç¾å¨ç·å¥³ã¨ãã«ï¼ï¼ã¾ã§ã§ãããç·æ§ã¯ï¼ï¼ï¼ï¼ã¾ã§ã女æ§ã¯ï¼ï¼ï¼ï¼ã¾ã§ã¨ãªãã¾ããã ããã«ä¸æ§èèªã¯ãç¾å¨ï¼ï¼ï¼ã¾ã§ã§ãããç·æ§ã§ã¯ï¼ï¼ï¼ã¾ã§ã¨ãªãã¾ããã æªçã³ã¬ã¹ãã
è¡å§ãã³ã¬ã¹ããã¼ã«å¤ãªã©ãå¥åº·è¨ºæã®çµæã«ä¸åä¸æãã¦ããåããå°ãªããªããã¨æããããã人éããã¯å¦ä¼ãå¥ä¿é£ãå¥åº·è¨ºæçµæã«å¯¾ããæ°ããåºæºå¤ãçºè¡¨ããï¼NHKãã¥ã¼ã¹ãMSNç£çµãã¥ã¼ã¹ï¼ã ãã¨ãã°BMIã«ã¤ãã¦ã¯ããã¾ã§25以ä¸ããè¥æºãå¤å®ã ã£ãããããã27.7ã¾ã§ç·©åããããè¡å§ã«ã¤ãã¦ããå°ãåã«ãæé«è¡å§130以ä¸ãé«è¡å§ãã¨åºæºãå³ãããªã大éã®é«è¡å§æ£è ãçã¿åºããããä»åããã147ã¾ã§ç·©åãããã æ°åºæºã¯ç´150ä¸äººã®å¥è¨ºãã¼ã¿ããã¼ã¹ã«å¥åº·ãªäººç´34ä¸äººãæ½åºããã®ãã¡ç´1ä¸äººã®æ¤æ»å¤ããã¼ã¹ã«ä¸éã¨ä¸éã決ããã¨ããã
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}